|Articles|August 1, 2002

Caspofungin adds to aspergillosis armamentarium

New Orleans - The novel antifungal agent caspofungin (Cancidas) is a helpful addition to the armamentarium of medications that are currently used to treat aspergillosis, according to Tamara Koss, M.D. It may be a particularly appropriate modality in immunocompromised patients who have not responded to conventional antimycotics, she said.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


Latest CME